Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
Key Points
Key points are not available for this paper at this time.
Abstract
Cancer Research UK.
AI से पूछें
Like
Bookmark
Share
View Full Paper
AI से पूछें
Like
Bookmark
Share
View Full Paper
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial | Synapse